Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,832,000 | 8,521,000 | 6,098,000 | 9,746,000 | 12,182,000 |
| Marketable Securities | 47,000 | 1,440,000 | 1,474,000 | 84,000 | 67,000 |
| Receivables | 10,743,000 | 11,237,000 | 10,733,000 | 9,977,000 | 9,281,000 |
| Inventories | 3,172,000 | 3,396,000 | 3,483,000 | 3,128,000 | 3,094,000 |
| TOTAL | $30,364,000 | $29,100,000 | $26,509,000 | $27,928,000 | $28,957,000 |
| Non-Current Assets | |||||
| PPE Net | 4,893,000 | 4,958,000 | 5,075,000 | 5,110,000 | 5,130,000 |
| Investments And Advances | 235,000 | 244,000 | 260,000 | 277,000 | 272,000 |
| Intangibles | 100,451,000 | 103,851,000 | 106,284,000 | 108,330,000 | 109,752,000 |
| Other Non-Current Assets | 5,382,000 | 5,033,000 | 5,083,000 | 4,884,000 | 4,747,000 |
| TOTAL | $110,961,000 | $114,086,000 | $116,702,000 | $118,601,000 | $119,901,000 |
| Total Assets | $141,325,000 | $143,186,000 | $143,211,000 | $146,529,000 | $148,858,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,207,000 | 11,930,000 | 9,952,000 | 12,495,000 | 6,672,000 |
| Accounts payable and accrued liabilities | 23,505,000 | 22,543,000 | 22,569,000 | 22,699,000 | 21,861,000 |
| TOTAL | $32,712,000 | $34,473,000 | $32,521,000 | $35,194,000 | $28,533,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 60,399,000 | 61,002,000 | 63,522,000 | 64,189,000 | 74,049,000 |
| Other Non-Current Liabilities | 30,212,000 | 30,764,000 | 28,020,000 | 28,700,000 | 29,096,000 |
| TOTAL | $92,586,000 | $94,025,000 | $94,376,000 | $95,899,000 | $106,748,000 |
| Total Liabilities | $125,298,000 | $128,498,000 | $126,897,000 | $131,093,000 | $135,281,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,768,481 | 1,768,097 | 1,767,110 | 1,768,754 | 1,767,880 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 4,953,000 | 3,516,000 | 5,103,000 | 3,127,000 | 1,600,000 |
| Other shareholders' equity | -3,410,000 | -3,161,000 | -2,953,000 | -2,871,000 | -3,129,000 |
| TOTAL | $16,027,000 | $14,688,000 | $16,314,000 | $15,436,000 | $13,577,000 |
| Total Liabilities And Equity | $141,325,000 | $143,186,000 | $143,211,000 | $146,529,000 | $148,858,000 |